CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +500 | $2.27 | $1K | 196,628,113 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +49,249 | $2.28 | $112K | 196,677,362 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +27,700 | $2.28 | $63K | 196,705,062 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +35,734 | $2.29 | $82K | 196,740,796 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +24,400 | $2.29 | $56K | 196,765,196 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +52,210 | $2.30 | $120K | 196,817,406 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +600 | $2.30 | $1K | 196,818,006 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +2,364 | $2.30 | $5K | 196,820,370 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +3,500 | $2.30 | $8K | 196,823,870 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +69,986 | $2.30 | $161K | 196,893,856 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +11,375 | $2.31 | $26K | 196,905,231 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +804 | $2.31 | $2K | 196,906,035 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +43,656 | $2.32 | $101K | 196,949,691 |
| 2022-08-05 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +7,003 | $2.32 | $16K | 196,956,694 |
| 2022-07-14 | Yu Alice Lin-Tsing Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-07-14 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2022-07-14 | PAGANELLI JOHN A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-07-14 | MEDEL ROGER MD Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-07-14 | Lachman Prem A Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-07-14 | KRASNO RICHARD M Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 19 of 33 · 653 trades